Treatment of Subclinical Hyperthyroidism

Terminated

• Conditions: Subclinical Hyperthyroidism; Atrial Fibrillation

• Registration Number: NCT00213720
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Objective: To determine if the treatment of subclinical hyperthyroidism will reduce the rate of atrial fibrillation, the main complication of this condition.

Detailed Description

Randomized open-labelled multicentre study comparing radioiodine vs medical supervision without treatment

Study Timeline

• Study Start: 2005-08
• Study First Submitted: 2005-09-13
• Study First Submitted QC: 2005-09-13
• Study First Posted: 2005-09-21
• Status Verified: 2019-08
• Primary Completion: 2019-11
• Study Completion: 2020-01
• Last Update Submitted: 2020-09-25
• Last Update Posted: 2020-09-29

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 145

Inclusion Criteria

• Men and women aged 50 and greater
• Isolated decreased thyroid-stimulating hormone (TSH) with normal FT4 and FT3 levels

Exclusion Criteria

• Iodide overload
• Non sinusal heart rhythm
• Severe heart disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (21)

Patrick Roger; 🇫🇷 Bordeaux, France

Philippe Thiéblot; 🇫🇷 Clermont-Ferrand, France

Jean-Marcel Brun; 🇫🇷 Dijon, France

Jean-Louis Wemeau; 🇫🇷 Lille, France

Marie-Pierre Teissier; 🇫🇷 Limoges, France

Jacques Orgiazzi; 🇫🇷 Lyon, France

Bernard Conte-Delvox; 🇫🇷 Marseille, France

CH de Montbrison; 🇫🇷 Montbrison, France

Jacques Bringer; 🇫🇷 Montpellier, France

Marc Klein; 🇫🇷 Nancy, France

Scroll for more (11 remaining)